NEPHROPLUS vs VAISHALI: Stock Comparison
Nephrocare Health Services Ltd is the larger company by market capitalisation. Nephrocare Health Services Ltd shows a higher ROE, lower leverage and a higher net margin, while Vaishali Pharma Ltd shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
NEPHROPLUS leads 6; VAISHALI leads 1 of 8
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NEPHROPLUS | VAISHALI |
|---|---|---|
| Sector | — | Healthcare |
| Industry | — | Pharmaceuticals |
Price
| Metric | NEPHROPLUS | VAISHALI |
|---|---|---|
| Live Price | ₹697.35 | ₹7.97 |
| Day Change | 1.47% | -1.85% |
| Volume | 1.46 L | 93,607 |
| 52-Week High | ₹769.75 | ₹12.75 |
| 52-Week Low | ₹446 | ₹4.75 |
| Distance from 52W High | -9.41% | -37.49% |
Valuation
| Metric | NEPHROPLUS | VAISHALI |
|---|---|---|
| Market Cap | ₹6,991 Cr | ₹105 Cr |
| P/E Ratio | 89.97x | — |
| P/B Ratio | 6.19x | — |
| EPS | ₹7.66 | ₹0.32 |
| Book Value | ₹111 | ₹5.3 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | NEPHROPLUS | VAISHALI |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 18.35% |
| EPS Growth (TTM YoY) | 0% | -76.71% |
| Qtr Sales Growth | 21.2% | — |
| Qtr Profit Growth | 22.1% | — |
Profitability & Leverage
| Metric | NEPHROPLUS | VAISHALI |
|---|---|---|
| ROE | 9.06% | 6.02% |
| ROCE | 15.5% | — |
| Net Margin | 7.69% | 3.83% |
| Operating Margin | 22.4% | 3.78% |
| Debt to Equity | 0.07x | 0.27x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | NEPHROPLUS | VAISHALI |
|---|---|---|
| Promoter Holding | 21.07% | 31.61% |
| FII Holding | 8.78%▼ 1.16 pp | 0% |
| DII Holding | 9.05%▲ 0.4 pp | 0% |
| Public Holding | 18.32%▲ 0.76 pp | 68.39% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Nephrocare Health Services Ltd and Vaishali Pharma Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.